Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First-in-Human Early Feasibility Study of Safety, Tolerability and Efficacy for a Multichannel Vestibular Implant in Individuals With Bilateral Severe-to-Profound Loss of Vestibular Sensation

NCT02725463 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT02725463
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02725463 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First-in-Human Early Feasibility Study of Safety, Tolerability and Efficacy for a Multichannel Vestibular Implant in Individuals With Bilateral Severe-to-Profound Loss of Vestibular Sensation
Lead sponsor
Johns Hopkins University
Phase
Not applicable
Overall status
Active, not recruiting
Start date
April 30, 2016
Completion date
March 31, 2028
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bilateral vestibular deficiency (bvd), gentamicin ototoxicity, labyrinth diseases, other disorders of vestibular function, bilateral, sensation disorders, vestibular diseases